Alligator Bioscience receives government research grant
Lund, Sweden, October 5, 2018 – Alligator Bioscience AB (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today announced that they will receive a 500 000 SEK grant from Sweden's government agency for innovation, Vinnova, for the project “Verification of the unique functionality of ATOR-1017 by 3D structure determination”. The project category was “Industrial pilot projects for neutron- and photon-based experiments at large-scale research infrastructures". The grant will be used to obtain, in collaboration with